Skip to content
Screener

Total debt at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$242K-64.4%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$2.07M+36.3%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$64.36M+7.4%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$4.9M+61.8%
Alumis Inc. logo
Alumis Inc.ALMS
$35.66M+1,881%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$83.16M-17.1%

Other financials

Income statement

See full
Revenue$700.0K-53.3%
Operating income-$50.6M-23.1%
Net income-$50.4M-20.3%
EPS (diluted)-$0.12+61.3%

Balance sheet

See full
Cash & equivalents$174.9M+69.5%
Total equity$160.4M+86.1%
Total assets$223.2M+55.6%

Cash flow

See full
Operating cash flow-$52.6M-55.2%
CapEx$400.0K
Free cash flow-$53.0M-56.3%

Valuation

See full
Market cap$847.16M+218%
Enterprise value$679.96M+297%
P/S168.8×+100×

Profitability

See full
Operating margin-3,543.1%+523pp
Net margin-3,506.5%+442pp
FCF margin-3,399.3%+3,268pp

Returns & leverage

See full
Return on equity-142.7%-5.0pp
Debt / equity0.0×
Current ratio3.7×+1.3×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $7.7M.

The source filing: DBV Technologies’s 10-Q, filed July 16, 2026. Open the filing →

Filed
Jul 16, 2026, 4:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-048453

FAQ

What is DBV Technologies's total debt?
DBV Technologies (DBVT) reported total debt of $7.7M in Q2 2026.
How has DBV Technologies's total debt changed year-over-year?
DBV Technologies's total debt increased by 0.1% year-over-year, from $7.7M to $7.7M.
What is the long-term trend for DBV Technologies's total debt?
Over 5 years (2020 to 2025), DBV Technologies's total debt has grown at a -14.5% compound annual growth rate (CAGR), from $14.21M to $6.5M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.

Ask your AI about DBV Technologies's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude